Katherine Stueland - Oct 29, 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Executive Officer, Director
Signature
/s/ Bridget Brown, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Oct 29, 2024
Transactions value $
-$143,456
Form type
4
Date filed
10/31/2024, 05:13 PM
Previous filing
Sep 18, 2024
Next filing
Nov 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $0 +3.87K +3.74% $0.00 108K Oct 29, 2024 Direct F1
transaction WGS Class A Common Stock Sale -$143K -2.15K -2% $66.60 105K Oct 29, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -3.87K -14.29% $0.00 23.2K Oct 29, 2024 Class A Common Stock 3.87K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
F3 25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.